February 6, 2015

Prestige Brands will be resuming healthcare professional marketing programs in support of its Monistat vaginal treatments.

February 5, 2015

There is a sharp spike in cough-cold promotion across retail circulars in the back-to-school season, according to an analysis of circular retail promotions provided by ECRM, as moms prepare their families for the inevitable season of sniffles and sneezes with the coming school year.

February 5, 2015

Merck earlier this week announced that Belsomra (suvorexant) is now available at pharmacies in the United States for the treatment of insomnia.

February 4, 2015

Procter & Gamble’s Gillette is promising a rust-free bathroom with its new Gillette Fusion ProGlide Sensitive 2-in-1 Shave Gel Plus Skin Care.

February 3, 2015

Teva Pharmaceuticals on Tuesday announced the introduction of dexmethylphenidate hydrochloride extended-release capsules, CII, in 10-mg dosage strength.

February 3, 2015

Zogenix last week announced that the Food and Drug Administration approved a new formulation of the company's Zohydro ER (hydrocodone bitartrate) extended-release capsules, CII.

January 30, 2015

Janssen Therapeutics on Thursday announced that the Food and Drug Administration has approved its Prezcobix (darunavir 800 mg/cobicistat 150 mg) tablets. The drug is used to treat human immunodeficiency virus in combination with other antiretovirals for treatment-naïve and treatment-experienced adults with no darunavir resistance-associated substitutions, according to the company.

 

January 27, 2015

Dietary supplement manufacturers should include a daily serving of at least 150 mcg of iodine in all multivitamin/mineral supplements intended for pregnant and lactating women in the United States, the Council for Responsible Nutrition advised in guidelines for industry released Tuesday. 

January 27, 2015

The Food and Drug Administration on Monday announced approval for the first generic version of Nexium (esomeprazole magnesium delayed-release capsules), which are used to treat gastroesophageal reflux disease in adults and children ages 1 year and older.

January 27, 2015

Symplmed Pharmaceuticals announced that the Food and Drug Administration approved Prestalia (perindopril arginine and amlodipine) tablets to treat hypertension. 

January 27, 2015

Teva Pharmaceutical Industries announced that the Food and Drug Administration approved the company’s first generic Nexium delayed-release tablets in the United States.

January 26, 2015

Procter & Gamble’s Old Spice brand has unveiled a new product lineup dubbed the Fresher Collection, which is inspired by the freshest ingredients in nature.

January 26, 2015

Purdue Pharma on Monday announced the launch of Hysingla ER (hydrocodone bitartrate) extended-release tablets CII. According to the company, the once-daily drug is the first and only hydocodone product to be recognized by the Food and Drug Administration as having properties that deter misuse and abuse via chewing, snorting and injection.

January 22, 2015

Camber Pharmaceuticals on Thursday announced the launch of pantoprazole sodium delayed-release tablets USP, the generic version of Pfizer's Protonix. The drug is used to treat gastro esophageal reflux disease and damage to the esophagus.

 

January 22, 2015

Glucose Health recently launched a powder blend that can assist in the stabilization of healthy glucose levels, the company announced.

January 21, 2015

Boehringer Ingelheim Pharmaceuticals on Wednesday announced that its Spiriva Respimat (tiotropium bromide) inhalation spray is now available by prescription through pharmacies across the United States. 

 

January 16, 2015

AbbVie announced that the Food and Drug Administration has approved its Duopa (carbidopa and levodopa) enteral suspension, which is used to treat motor fluctuations for people with advanced Parkinson's disease. 

 

January 15, 2015

Mylan on Thursday announced the launch of lamivudine tablets, 100 mg, the generic version of Epivir-HBV from GlaxoSmithKline. 

January 14, 2015

Egalet Corp. last week announced the licensing and acquisition of two pain products. Egalet has agreed to license worldwide rights to Oxaydo (oxycodone HCI, USP) tablets for oral use only -CII, the first and only approved immediate-release oxycodone product formulated to deter abuse via snorting from Acura Pharmaceuticals, the company stated.

January 14, 2015

Following a successful test of three in-store health clinics, Bartell Drugs is looking to expand the initiative and roughly double the number of clinics in 2015, according to a local news report.

January 13, 2015

Prasco Labs., Takeda Pharmacuetical Company Limited and Takeda's wholly owned subsidiary Takeda Pharmaceuticals U.S.A. on Tuesday announced that Prasco and TPUSA entered into a distribution and supply agreement for the rights to distribute colchicine tablets, USP, the authorized generic of Colcrys tablets. 

 

January 12, 2015

Perrigo and Ferrara Candy Co. announced Monday that Perrigo's Nutritionals division has signed a supply agreement with Ferrara to manufacture store brand gummy vitamins and dietary supplements.

January 12, 2015

Perrigo on Monday announced that it has launched clobetasol propionate spray, 0.05%, the generic equivalent to Clobex spray, 0.05%. 

January 12, 2015

The Pharmacy Quality Alliance on Monday announced the retirement of the performance measure, "Diabetes: Appropriate Treatment of Hypertension."